To this end, we investigated how δ-tocotrienol inhibits pancreatic cancer cell growth and identified the cyclin-dependent kinase (CDK) inhibitor p27Kip1 as a molecular target of δ-tocotrienol. The gene discussed is CDKN1B; the disease is pancreatic neoplasm.